Marvel Biosciences Corp. (MRVL.V)
- Baystreet
Stocks in play: Marvel Biosciences Corp
And its wholly owned subsidiary, Marvel Biotechnology Inc, announces that it has initiated the 4-week ...
- Newsfile
Marvel Commences Final Study Required Prior to Initiating Human Trials
Calgary, Alberta--(Newsfile Corp. - March 21, 2023) - Marvel Biosciences Corp. (TSXV: MRVL) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"), is pleased to announce that it has initiated the 4-week good laboratory practice (GLP) FDA investigational new drug (IND) enabling dose-ranging dog studies for its lead drug candidate MB-204."This dog study is the last of the two key primary animal studies we need to complete before entering phase ...
- Newsfile
Marvel Biosciences Initiates Four Week Rat GLP Toxicology Study
Calgary, Alberta--(Newsfile Corp. - March 9, 2023) - Marvel Biosciences Corp. (TSXV: MRVL) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"), is pleased to announce that it has initiated the 4-week good laboratory practice (GLP) FDA investigational new drug (IND) enabling dose-ranging rat studies for its lead drug candidate MB-204."This rat study, along with the GLP study on dogs, are the last two key studies we need to complete ...
